Follow
Nanologica AB
Spotlight (Sweden)
Nanologica was founded in 2004 and is a nanotechnology company developing nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size and type of porosity of silica particles. This knowledge is applied within drug development and chromatography (a separation technique used in drug development and drug production). The company’s mission is to contribute to better and cheaper treatments for patients worldwide through the technology platform NLAB Nanologica was founded in 2004 and is a nanotechnology company developing nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size and type of porosity of silica particles. This knowledge is applied within drug development and chromatography (a separation technique used in drug development and drug production). The company’s mission is to contribute to better and cheaper treatments for patients worldwide through the technology platform NLAB Silica™.

Read more

Sector:
HEALTH CARE
>
Life Sciences Tools & Services
Pharmaceuticals, Biotechnology & Life Sciences
Media
Current instruments
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
NICA
SE0005454873
Spotlight
Sweden (SE)
Details of share in Nanologica AB with ticker NICA
Status
Active
Order book id
413C
Amount of instruments
16 619 447
Par value
0.4100
Market cap
147 900 000.00 SEK
Currency
SEK
First trading date
30 Oct 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
20.50 SEK
38.8M SEK
08 Sep - 24 Sep 2015
IPO in Nanologica AB
Market
Spotlight
Subscription period
08 Sep - 24 Sep 2015
Subscription price
Price per share
20.50 SEK
Target to raise
22 000 000 SEK
Types
Pre-money valuation
38 800 000 SEK
Subscription block size
Minimum subscription
400
Record date
Offer status
Closed
Listing status
Listed
First trading date
30 Oct 2015
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
18.00 SEK
60.5M SEK
21 Sep - 05 Oct 2016
Share issue in Nanologica AB
Market
Spotlight
Subscription period
21 Sep - 05 Oct 2016
Subscription price
Price per share
18.00 SEK
Target to raise
22 700 000 SEK
Types
Share issue
Pre-money valuation
60 500 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 3:8.
Type
Price
Pre-money valuation
Time
Files
New issue
4.00 SEK
18.5M SEK
20 Apr - 04 May 2018
Share issue in Nanologica AB
Market
Spotlight
Subscription period
20 Apr - 04 May 2018
Subscription price
Price per share
4.00 SEK
Target to raise
55 400 000 SEK
Types
Share issue
Pre-money valuation
18 500 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 3:1.
Type
Price
Pre-money valuation
Time
Files
New issue
10.00 SEK
166.2M
12 Mar - 26 Mar 2020
Share issue in Nanologica AB
Market
Spotlight
Subscription period
12 Mar - 26 Mar 2020
Subscription price
10.00 SEK
Price per share
10.00 SEK
Target to raise
55 400 000
Types
Share issue
Pre-money valuation
166 200 000
Subscription block size
Minimum subscription
Record date
09 Mar 2020
Offer status
Closed
Listing status
Listed
Issue terms
For each share in the Company held on the record date, one (1) subscription right is obtained, three (3) subscription rights entitle to subscribe for one (1) new share.
Comments for offer & related information
The company shall issue a maximum of 5 539 815 shares. In the event that the Rights Issue is over-subscribed, the Board of Directors intends to make decisions on the issue of additional shares in accordance with the Over-allotment Option, which upon full exercise gives the Company an additional SEK 7.5 million. The rights issue is covered 100% by subscription commitments from existing shareholders.
Result of offer
The final outcome shows that the Rights Issue was fully subscribed, where 42.0 percent was subscribed with the support of subscription rights and 11.5 percent subscribed without the support of subscription rights. The remaining share, corresponding to 46.4 per cent, was subscribed by the Company's largest shareholder, Thomas Eldered via the company Flerie Invest AB, in accordance with the guarantee undertaking. Nanologica is thus allocated SEK 55.4 million before issue costs, which are estimated to amount to about SEK 2.9 million.
People
Number of Employees
19 people
Andreas Bhagwani
CEO
Gisela Sitbon
Chairman of the board
Eva Byröd
Board member
Hans Lennernäs
Board member
Lena Torlegård
Board member
Mattias Bengtsson
Board member
Company Details
Sector
HEALTH CARE

Address
Forskargatan 20 G
Zip code
151 36
City/district
Södertälje
Country
Sweden (SE)
Registration number
556664-5023
LEI code
54930017L41C7P87LP22
First trade date
30 Oct 2015
Registration date
30 Jul 2004
Short name
Nanologica

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date